Cargando…
The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system and has a 5-year overall survival rate of 14.1%. Many HCC patients are diagnosed at an advanced stage, and thus early screening is essential for reducing the mortality of HCC. In addition to commonly us...
Autores principales: | Ding, Jingnuo, Zhao, Weifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484767/ https://www.ncbi.nlm.nih.gov/pubmed/36133739 http://dx.doi.org/10.2147/CMAR.S373165 |
Ejemplares similares
-
Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022) -
Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
por: Mocan, Tudor, et al.
Publicado: (2020) -
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021) -
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
por: Pelizzaro, Filippo, et al.
Publicado: (2021) -
Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)